Keynote Speech: ’’Ketamine for Suicidal Depression:
Evidence of Efficacy is in Hand & the Risks Must be Balanced’’
from the the 7th Annual Neuroscience Innovation Forum

by Jonathan Javitt, Founder & Chief Scientist, NRx Pharmaceuticals, Inc.